Medicine News

• Rotarix? Significantly Reduced Severe Rotavirus Gastroenteritis In African Babies During ...
  Sat, 30 January 2010
  The New England Journal of Medicine (NEJM) published the first study demonstrating that Rotarix?, GlaxoSmithKline's rotavirus vaccine, significantly prevented severe rotavirus gastroenteritis during the first year of life in African babies. In the study Rotarix prevented the disease in 61.2% of these infants. The study also ...
• GSK's TYKERB Receives Accelerated Approval For First-line Combination Treatment Of Hormo ...
  Sat, 30 January 2010
  GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for a new combination regimen using TYKERB (lapatinib) as a first-line, all-oral treatment for women with metastatic breast cancer...
• Merck Receives European Approval For ELONVA (corifollitropin Alfa Injection), A New Fert ...
  Sat, 30 January 2010
  Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, announced the European Commission (EC) approval of ELONVA (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating ...
• Novo Nordisk Receives US Approval For Victoza (liraglutide) For The Treatment Of Type 2 ...
  Sat, 30 January 2010
  Novo Nordisk receives US approval for Victoza (liraglutide) for the treatment of type 2 diabetes Novo Nordisk announced today that the US Food and Drug Administration (FDA) has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults...
• Bayer Starts Clinical Phase I Study With Personalized Vaccine From Tobacco Plants
  Sat, 30 January 2010
  The transfer into clinical development of a patient-specific vaccine represents a milestone for Bayer Innovation GmbH. Following approval of the Phase I study by the FDA (Food & Drug Administration) in the United States, the vaccine is now being tested in human subjects. This is the first time that proteins obtained from tob ...
• Cancer Medicines Pipeline Offers Patients Great Hope
  Sat, 30 January 2010
  The Bienville Democrat in Arcadia, LA recently reported that America's pharmaceutical research and biotechnology companies have made great progress in treating cancers, introducing many new, breakthrough medicines...
• Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results Of Perifosine As A Sin ...
  Sat, 30 January 2010
  Keryx Biopharmaceuticals, Inc...
• BIO Debuts Livestock Biotech Summit
  Fri, 29 January 2010
  The Biotechnology Industry Organization (BIO) announced today its newest conference, the Livestock Biotech Summit, scheduled for September 28-30, 2010, in Sioux Falls, S.D...
• BIO Welcomes President Obama's Remarks On Advanced Biofuels
  Fri, 29 January 2010
  The United States can lead the world in deploying advanced biotechnology for biofuels and create thousands of new jobs by implementing policies to support the emerging industry...
• Conatus Pharmaceuticals Initiates Phase II Clinical Trial In Combination With Pegylated ...
  Fri, 29 January 2010
  Conatus Pharmaceuticals Inc. announced the initiation of a Phase II clinical trial evaluating CTS-1027 in combination with pegylated interferon (Pegasys) and ribavirin (Copegus) in refractory HCV patients. Antiviral activity, safety and tolerability of the triple combination will be assessed after up to 48 weeks of therapy...